Inherited causes of exocrine pancreatic insufficiency in pediatric patients: clinical presentation and laboratory testing

References

• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Pancreatitis in Children 2020. Available from: https://www.niddk.nih.gov/news/archive/2020/story-discovery-prancreatitis-children.
   Google Scholar
• Cystic Fibrosis Foundation, Bethesda MD, www.cff.org., (accessed Sept 20, 2022. Bethesda, MD.
   Google Scholar
• Guo J, Garratt A, Hill A. Worldwide rates of diagnosis and effective treatment for cystic fibrosis. J Cyst Fibros. 2022 ;21(3):456–462.
   PubMedGoogle Scholar
• Shteinberg M, Haq IJ, Polineni D, et al. Cystic fibrosis. Lancet. 2021;397(10290):2195–2211.
   PubMed Web of Science ®Google Scholar
• Angyal D, Bijvelds MJC, Bruno MJ, et al. Bicarbonate transport in cystic fibrosis and pancreatitis. Cells. 2021;11(1):54.
   PubMed Web of Science ®Google Scholar
• Kayani K, Mohammed R, Mohiaddin H. Cystic fibrosis-related diabetes. Front Endocrinol . 2018;9:20.
   PubMed Web of Science ®Google Scholar
• Kerem E, Corey M, Kerem BS, et al. The relation between genotype and phenotype in cystic fibrosis–analysis of the most common mutation (Delta F508). N Engl J Med. 1990; 323(22):1517–1522.
   PubMed Web of Science ®Google Scholar
• Durie PR, Forstner GG. Pathophysiology of the exocrine pancreas in cystic fibrosis. J R Soc Med. 1989;82(Suppl 16):2–10.
   PubMedGoogle Scholar
• O'Sullivan BP, Baker D, Leung KG, et al. Evolution of pancreatic function during the first year in infants with cystic fibrosis. J Pediatr. 2013;162(4):808–812.e1.
   PubMed Web of Science ®Google Scholar
• De Boeck K, Weren M, Proesmans M, et al. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. Pediatrics. 2005; 115(4):e463-9–e469.
   PubMed Web of Science ®Google Scholar
• Durno C, Corey M, Zielenski J, et al. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology. 2002; 123(6):1857–1864.
   PubMed Web of Science ®Google Scholar
• Ooi CY, Dorfman R, Cipolli M, et al. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology. 2011; 140(1):153–161.
   PubMed Web of Science ®Google Scholar
• Guda NM, Muddana V, Whitcomb DC, et al. Recurrent acute pancreatitis: international state-of-the-science conference with recommendations. Pancreas. 2018; 47(6):653–666.
   PubMed Web of Science ®Google Scholar
• Freeman AJ, Ooi CY. Pancreatitis and pancreatic cystosis in cystic fibrosis. J Cyst Fibros. 2017;16 Suppl 2(Suppl 2):S79–S86.
   PubMedGoogle Scholar
• Sellers ZM. Pancreatic complications in children with cystic fibrosis. Curr Opin Pediatr. 2020;32(5):661–667.
   PubMed Web of Science ®Google Scholar
• Freswick PN, Reid EK, Mascarenhas MR. Pancreatic enzyme replacement therapy in cystic fibrosis. Nutrients. 2022;14(7):1341.
   PubMed Web of Science ®Google Scholar
• Singh VK, Schwarzenberg SJ. Pancreatic insufficiency in cystic fibrosis. J Cyst Fibros. 2017;16(Suppl 2):S70–S78.
   PubMed Web of Science ®Google Scholar
• Scotet V, Gutierrez H, Farrell PM. Newborn screening for CF across the globe – Where is it worthwhile? Int J Neonatal Screen. 2020; 6(1):18.
   PubMed Web of Science ®Google Scholar
• Comeau AM, Parad RB, Dorkin HL, et al. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics. 2004; 113(6):1573–1581.
   PubMed Web of Science ®Google Scholar
• Pique L, Graham S, Pearl M, et al. Cystic fibrosis newborn screening programs: implications of the CFTR variant spectrum in nonwhite patients. Genet Med. 2017;19(1):36–44.
   PubMed Web of Science ®Google Scholar
• Bell SC, Mall MA, Gutierrez H, et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med. 2020; 8(1):65–124.
   PubMed Web of Science ®Google Scholar
• Brownell JN, Bashaw H, Stallings VA. Growth and nutrition in cystic fibrosis. Semin Respir Crit Care Med. 2019;40(6):775–791.
   PubMed Web of Science ®Google Scholar
• Reilly JJ, Edwards CA, Weaver LT. Malnutrition in children with cystic fibrosis: the energy-balance equation. J Pediatr Gastroenterol Nutr. 1997;25(2):127–136.
   PubMed Web of Science ®Google Scholar
• Stephenson AL, Mannik LA, Walsh S, et al. Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study. Am J Clin Nutr. 2013; 97(4):872–877.
   PubMed Web of Science ®Google Scholar
• Yen EH, Quinton H, Borowitz D. Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis. J Pediatr. 2013;162(3):530–535 e1.
   PubMed Web of Science ®Google Scholar
• Daftary A, Acton J, Heubi J, et al. Fecal elastase-1: utility in pancreatic function in cystic fibrosis. J Cyst Fibros. 2006;5(2):71–76.
   PubMed Web of Science ®Google Scholar
• Struyvenberg MR, Martin CR, Freedman SD. Practical guide to exocrine pancreatic insufficiency - Breaking the myths. BMC Med. 2017; 15(1):29.
   PubMedGoogle Scholar
• Bierlaagh MC, Muilwijk D, Beekman JM, et al. A new era for people with cystic fibrosis. Eur J Pediatr. 2021; 180(9):2731–2739.
   PubMed Web of Science ®Google Scholar
• Fortner CN, Seguin JM, Kay DM. Normal pancreatic function and false-negative CF newborn screen in a child born to a mother taking CFTR modulator therapy during pregnancy. J Cyst Fibros. 2021; 20(5):835–836.
   PubMed Web of Science ®Google Scholar
• Davies JC, Cunningham S, Harris WT, et al. Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study. Lancet Respir Med. 2016;4(2):107–115.
   PubMed Web of Science ®Google Scholar
• Rosenfeld M, Cunningham S, Harris WT, et al. An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2–5years (KLIMB). J Cyst Fibros. 2019;18(6):838–843.
   PubMed Web of Science ®Google Scholar
• Rosenfeld M, Wainwright CE, Higgins M, et al. Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study. Lancet Respir Med. 2018; 6(7):545–553.
   PubMed Web of Science ®Google Scholar
• Stallings VA, Sainath N, Oberle M, et al. Energy balance and mechanisms of weight gain with ivacaftor treatment of cystic fibrosis gating mutations. J Pediatr. 2018;201:229–237.e4.
   PubMed Web of Science ®Google Scholar
• Megalaa R, Gopalareddy V, Champion E, et al. Time for a gut check: pancreatic sufficiency resulting from CFTR modulator use. Pediatr Pulmonol. 2019;54(8):E16–e18.
   PubMed Web of Science ®Google Scholar
• Smith H, Rayment JH. Sustained recovery of exocrine pancreatic function in a teenager with cystic fibrosis treated with ivacaftor. Pediatr Pulmonol. 2020; 55(10):2493–2494. `
   PubMed Web of Science ®Google Scholar
• Munce D, Lim M, Akong K. Persistent recovery of pancreatic function in patients with cystic fibrosis after ivacaftor. Pediatr Pulmonol. 2020; 55(12):3381–3383.
   PubMed Web of Science ®Google Scholar
• Akshintala VS, Kamal A, Faghih M, et al. Cystic fibrosis transmembrane conductance regulator modulators reduce the risk of recurrent acute pancreatitis among adult patients with pancreas sufficient cystic fibrosis. Pancreatology. 2019; 19(8):1023–1026.
   PubMed Web of Science ®Google Scholar
• Ramsey ML, Gokun Y, Sobotka LA, et al. Cystic fibrosis transmembrane conductance regulator modulator use is associated with reduced pancreatitis hospitalizations in patients with cystic fibrosis. Am J Gastroenterol. 2021;116(12):2446–2454.
   PubMed Web of Science ®Google Scholar
• Gould MJ, Smith H, Rayment JH, et al. CFTR modulators increase risk of acute pancreatitis in pancreatic insufficient patients with cystic fibrosis. J Cyst Fibros. 2022; 21(4):600–602.
   PubMed Web of Science ®Google Scholar
• McKay IR, Ooi CY. The exocrine pancreas in cystic fibrosis in the era of CFTR modulation: a mini review. Front Pediatr. 2022;10:914790.
   PubMed Web of Science ®Google Scholar
• Liu QY, Abu-El-Haija M, Husain SZ, et al. Risk factors for rapid progression from acute recurrent to chronic pancreatitis in children: report from INSPPIRE. J Pediatr Gastroenterol Nutr. 2019; 69(2):206–211.
   PubMed Web of Science ®Google Scholar
• LaRusch J, Lozano-Leon A, Stello K, et al. The common chymotrypsinogen C (CTRC) variant G60G (C.180T) Increases risk of chronic pancreatitis but not recurrent acute pancreatitis in a North American population. Clin Transl Gastroenterol. 2015;6(1):e68–e68.
   PubMedGoogle Scholar
• Gumaste VV, Roditis N, Mehta D, et al. Serum lipase levels in nonpancreatic abdominal pain versus acute pancreatitis. Am J Gastroenterol. 1993; 88(12):2051–2055.
   PubMed Web of Science ®Google Scholar
• Morinville VD, Husain SZ, Bai H, Definitions of pediatric pancreatitis and survey of present clinical practices. J Pediatr Gastroenterol Nutr. 2012;55(3):261–265.
   PubMed Web of Science ®Google Scholar
• Howes N, Lerch MM, Greenhalf W, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol. 2004; 2(3):252–261.
   PubMed Web of Science ®Google Scholar
• Majumder S, Chari ST. Chronic pancreatitis. Lancet. 2016;387(10031):1957–1966.
   PubMed Web of Science ®Google Scholar
• Gariepy CE, Heyman MB, Lowe ME, et al. Causal evaluation of acute recurrent and chronic pancreatitis in children: consensus from the INSPPIRE group. J Pediatr Gastroenterol Nutr. 2017;64(1):95–103.
   PubMed Web of Science ®Google Scholar
• Conwell DL, Lee LS, Yadav D, et al. American pancreatic association practice guidelines in chronic pancreatitis: evidence-based report on diagnostic guidelines. Pancreas. 2014;43(8):1143–1162.
   PubMed Web of Science ®Google Scholar
• Ellis I, Lerch MM, Whitcomb DC. Genetic testing for hereditary pancreatitis: guidelines for indications, counselling, consent and privacy issues. Pancreatology. 2001;1(5):405–415.
   PubMed Web of Science ®Google Scholar
• Goldstein A, Falk MJ, et al. Mitochondrial DNA deletion syndromes. In: Adam MP, Everman DB, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1116/.
   Google Scholar
• Pearson HA, Lobel JS, Kocoshis SA, et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr. 1979; 95(6):976–984.
   PubMed Web of Science ®Google Scholar
• Crippa BL, Leon E, Calhoun A, et al. Biochemical abnormalities in Pearson syndrome. Am J Med Genet A. 2015; 167A(3):621–628.
   PubMedGoogle Scholar
• Reynolds E, Byrne M, Ganetzky R, et al. Pediatric single large-scale mtDNA deletion syndromes: the power of patient reported outcomes. Mol Genet Metab. 2021; 134(4):301–308.
   PubMed Web of Science ®Google Scholar
• Wild KT, Goldstein AC, Muraresku C, et al. Broadening the phenotypic spectrum of pearson syndrome: five new cases and a review of the literature. Am J Med Genet A. 2020;182(2):365–373.
   PubMed Web of Science ®Google Scholar
• Grady JP, Campbell G, Ratnaike T, et al. Disease progression in patients with single, large-scale mitochondrial DNA deletions. Brain. 2014;137(Pt 2):323–334.
   PubMedGoogle Scholar
• Sadikovic B, Wang J, El-Hattab AW, et al. Sequence homology at the breakpoint and clinical phenotype of mitochondrial DNA deletion syndromes. PLOS One. 2010; 5(12):e15687.
   PubMed Web of Science ®Google Scholar
• Farruggia P, Di Cataldo A, Pinto RM, et al. Pearson syndrome: a retrospective cohort study from the marrow failure study group of A.I.E.O.P. Associazione Italiana Emato-Oncologia Pediatrica. JIMD Rep. 2016;26:37–43.
   Google Scholar
• Rotig A, Cormier V, Blanche S, et al. Pearson’s marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest. 1990;86(5):1601–1608.
   PubMed Web of Science ®Google Scholar
• Pronman L, Rondinelli M, Burkardt DD, et al. Pearson syndrome: a rare cause of failure to thrive in infants. Clin Pediatr . 2019; 58(7):819–824.
   PubMed Web of Science ®Google Scholar
• Zaffanello M, Zamboni G. Therapeutic approach in a case of pearson’s syndrome. Minerva Pediatr. 2005; 57(3):143–146.
   PubMedGoogle Scholar
• Ying Y, Liang Y, Luo X, et al. Case report: clinical and genetic characteristics of pearson syndrome in a chinese boy and 139 patients. Front Genet. 2022;13:802402.
   PubMed Web of Science ®Google Scholar
• Mack DR, Forstner GG, Wilschanski M, et al. Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology. 1996;111(6):1593–1602.
   PubMed Web of Science ®Google Scholar
• Bodian M, Sheldon W, Lightwood R. Congenital hypoplasia of the exocrine pancreas. Acta Paediatr. 1964 May;53:282–293.
   PubMed Web of Science ®Google Scholar
• Andolina JR, Morrison CB, Thompson AA, et al. Shwachman-Diamond syndrome: diarrhea, no longer required? J Pediatr Hematol Oncol. 2013; 35(6):486–489.
   PubMed Web of Science ®Google Scholar
• Farooqui SM, Ward R, Aziz M. Shwachman-Diamond syndrome. StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
   Google Scholar
• Sukalo M, Fiedler A, Guzmán C, et al. Mutations in the human UBR1 gene and the associated phenotypic spectrum. Hum Mutat. 2014;35(5):521–531.
   PubMed Web of Science ®Google Scholar
• Zenker M, Mayerle J, Reis A, et al. Genetic basis and pancreatic biology of Johanson-Blizzard syndrome. Endocrinol Metab Clin North Am. 2006; 35(2):243–253.
   PubMed Web of Science ®Google Scholar
• Vanlieferinghen PH, Borderon C, Francannet CH, et al. Johanson-Blizzard syndrome. a new case with autopsy findings. Genet Couns. 2001;12(3):245–250.
   PubMedGoogle Scholar
• Ellery KM, Erdman SH. Johanson-Blizzard syndrome: expanding the phenotype of exocrine pancreatic insufficiency. JOP. 2014; 15(4):388–390.
   PubMedGoogle Scholar
• Mitchell E, Gilbert M, Loomes KM. Alagille syndrome. Clin Liver Dis. 2018;22(4):625–641.
   PubMed Web of Science ®Google Scholar
• Burroughs L, Woolfrey A, Shimamura A. Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment. Hematol Oncol Clin North Am. 2009; 23(2):233–248.
   PubMed Web of Science ®Google Scholar
• Levin TL, Mäkitie O, Berdon WE, et al. Shwachman-bodian-diamond syndrome: metaphyseal chondrodysplasia in children with pancreatic insufficiency and neutropenia. Pediatr Radiol. 2015; 45(7):1066–1071.
   PubMed Web of Science ®Google Scholar
• Gliwicz D, Jankowska I, Wierzbicka A, et al. Exocrine pancreatic function in children with alagille syndrome. Sci Rep. 2016; 6:35229.
   PubMed Web of Science ®Google Scholar
• Kamath BM, Piccoli DA, Magee JC, et al. Pancreatic insufficiency is not a prevalent problem in alagille syndrome. J Pediatr Gastroenterol Nutr. 2012;55(5):612–614.
   PubMed Web of Science ®Google Scholar
• Manoli I, Sloan JL, Venditti CP, et al. Isolated methylmalonic acidemia. In: Adam MP, Everman DB, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1116/.
   Google Scholar
• Shchelochkov OA, Carrillo N, Venditti C, et al. Propionic acidemia. In: Adam MP, Everman DB, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1116/.
   Google Scholar
• Baumgartner MR, Horster F, Dionisi-Vici C, et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014; 9:130.
   PubMed Web of Science ®Google Scholar
• Fraser JL, Venditti CP. Methylmalonic and propionic acidemias: clinical management update. Curr Opin Pediatr. 2016;28(6):682–693.
   PubMed Web of Science ®Google Scholar
• Forny P, Horster F, Ballhausen D, et al. Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: first revision. J Inherit Metab Dis. 2021;44(3):566–592.
   PubMed Web of Science ®Google Scholar
• Bhoomagoud M, Jung T, Atladottir J, et al. Reducing extracellular pH sensitizes the acinar cell to secretagogue-induced pancreatitis responses in rats. Gastroenterology. 2009; 137(3):1083–1092.
   PubMed Web of Science ®Google Scholar
• Kahler SG, Sherwood WG, Woolf D, et al. Pancreatitis in patients with organic acidemias. J Pediatr. 1994;124(2):239–243.
   PubMed Web of Science ®Google Scholar
• Chandler RJ, Zerfas PM, Shanske S, et al. Mitochondrial dysfunction in mut methylmalonic acidemia. Faseb J. 2009;23(4):1252–1261.
   PubMed Web of Science ®Google Scholar
• Gallego-Villar L, Perez-Cerda C, Perez B, et al. Functional characterization of novel genotypes and cellular oxidative stress studies in propionic acidemia. J Inherit Metab Dis. 2013; 36(5):731–740.
   PubMed Web of Science ®Google Scholar
• Richard E, Alvarez-Barrientos A, Perez B, et al. Methylmalonic acidaemia leads to increased production of reactive oxygen species and induction of apoptosis through the mitochondrial/caspase pathway. J Pathol. 2007;213(4):453–461.
   PubMed Web of Science ®Google Scholar
• Schwab MA, Sauer SW, Okun JG, et al. Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. Biochem J. 2006;398(1):107–112.
   PubMed Web of Science ®Google Scholar
• Mukherjee R, Criddle DN, Gukovskaya A, et al. Mitochondrial injury in pancreatitis. Cell Calcium. 2008; 44(1):14–23.
   PubMed Web of Science ®Google Scholar
• Schoenberg MH, Birk D, Beger HG. Oxidative stress in acute and chronic pancreatitis. Am J Clin Nutr. 1995;62(6 Suppl):1306S–1314S.
   PubMed Web of Science ®Google Scholar
• Gilmore A, Bock HG, Nowicki M. Hyperamylasemia/hyperlipasemia in a child with propionic acidemia. Am J Med Genet A. 2008;146A(23):3090–3091.
   PubMed Web of Science ®Google Scholar
• Sutton VR, Chapman KA, Gropman AL, et al. Chronic management and health supervision of individuals with propionic acidemia. Mol Genet Metab. 2012; 105(1):26–33.
   PubMed Web of Science ®Google Scholar
• DiGregorio N, Sharma S. Physiology, secretin. . Treasure Island (FL): StatPearls Publishing Copyright © 2022.
   Google Scholar
• Jones MC, Vaqar S. Cholecystokinin test. . Treasure Island (FL): StatPearls Publishing Copyright © 2022.
   Google Scholar
• Pollack BJ, Grendell JH. Where have all the dreiling tubes gone? Am J Gastroenterol. 2006; 101(2):356–359.
   PubMed Web of Science ®Google Scholar
• Singh VK, Yadav D, Garg PK. Diagnosis and management of chronic pancreatitis: a review. Jama. 2019; 322(24):2422–2434.
   PubMed Web of Science ®Google Scholar
• Shandro BM, Nagarajah R, Poullis A. Challenges in the management of pancreatic exocrine insufficiency. World J Gastrointest Pharmacol Ther. 2018;9(5):39–46.
   PubMedGoogle Scholar
• Patel N, Sellers ZM, Grover A, et al. Endoscopic pancreatic function testing (ePFT) in children: a position paper from the NASPGHAN pancreas committee. J Pediatr Gastroenterol Nutr. 2021;72(1):144–150.
   PubMed Web of Science ®Google Scholar
• Horvath K, Mehta DI, Hill ID. Assessment of exocrine pancreatic function during endoscopy in children. J Pediatr Gastroenterol Nutr. 2019;68(6):768–776.
   PubMed Web of Science ®Google Scholar
• Gelfond D. A path to consensus on endoscopic pancreatic function testing. J Pediatr Gastroenterol Nutr. 2019;68(6):761–762.
   PubMed Web of Science ®Google Scholar
• Alfaro Cruz L, Parniczky A, Mayhew A, et al. Utility of direct pancreatic function testing in children. Pancreas. 2017;46(2):177–182.
   PubMed Web of Science ®Google Scholar
• Mehta DI, He Z, Bornstein J, et al. Report on the short endoscopic exocrine pancreatic function test in children and young adults. Pancreas. 2020;49(5):642–649.
   PubMed Web of Science ®Google Scholar
• Leeds JS, Oppong K, Sanders DS. The role of fecal elastase-1 in detecting exocrine pancreatic disease. Nat Rev Gastroenterol Hepatol. 2011;8(7):405–415.
   PubMed Web of Science ®Google Scholar
• Amanquah SD, Darko R, Maddy SQ, et al. Faecal pancreatic elastase–1 a non invasive measure of exocrine pancreatic function. West Afr J Med. 2004;23(3):240–244.
   PubMedGoogle Scholar
• Weiss FU, Budde C, Lerch MM. Specificity of a polyclonal fecal elastase ELISA for CELA3. PLOS One. 2016;11(7):e0159363.
   PubMed Web of Science ®Google Scholar
• Domínguez-Muñoz JE, Dh P, Lerch MM, et al. Potential for screening for pancreatic exocrine insufficiency using the fecal elastase-1 test. Dig Dis Sci. 2017;62(5):1119–1130.
   PubMed Web of Science ®Google Scholar
• Uc A, Fishman DS. Pancreatic disorders. Pediatr Clin North Am. 2017;64(3):685–706.
   PubMed Web of Science ®Google Scholar
• Löser C, Möllgaard A, Fölsch UR. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut. 1996;39(4):580–586.
   PubMed Web of Science ®Google Scholar
• Walkowiak J, Cichy WK, Herzig KH. Comparison of fecal elastase-1 determination with the secretin-cholecystokinin test in patients with cystic fibrosis. Scand J Gastroenterol. 1999; 34(2):202–207.
   PubMed Web of Science ®Google Scholar
• Wali PD, Loveridge-Lenza B, He Z, et al. Comparison of fecal elastase-1 and pancreatic function testing in children. J Pediatr Gastroenterol Nutr. 2012;54(2):277–280.
   PubMed Web of Science ®Google Scholar
• Meyts I, Wuyts W, Proesmans M, et al. Variability of fecal pancreatic elastase measurements in cystic fibrosis patients. J Cyst Fibros. 2002;1(4):265–268.
   PubMedGoogle Scholar
• Vanga RR, Tansel A, Sidiq S, et al. Diagnostic performance of measurement of fecal elastase-1 in detection of exocrine pancreatic insufficiency: Systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16(8):1220–1228.e4.
   PubMed Web of Science ®Google Scholar
• Beharry S, Ellis L, Corey M, et al. How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease? J Pediatr. 2002;141(1):84–90.
   PubMed Web of Science ®Google Scholar
• Garah J, Rosen I, Shaoul R. Transient exocrine pancreatic insufficiency in children: an existing entity? J Pediatr Gastroenterol Nutr. 2019; Apr68(4):574–577.
   PubMed Web of Science ®Google Scholar
• Wyness SP, Nelson HA, Jensen R, et al. Clinical and analytical characterization of the DiaSorin and ScheBo fecal pancreatic elastase 1 assays. Pancreas. 2022; Mar 151(3):243–249.
   PubMed Web of Science ®Google Scholar
• Sankararaman S, Schindler T, Sferra TJ. Management of exocrine pancreatic insufficiency in children. Nutr Clin Pract. 2019;34 Suppl 1(Suppl 1):S27–s42.
   PubMedGoogle Scholar
• Turck D, Braegger CP, Colombo C, et al. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin Nutr. 2016;35(3):557–577.
   PubMed Web of Science ®Google Scholar
• Münch A, Garten L, Bührer C. Protracted maturation of pancreatic-specific elastase 1 excretion in preterm infants of extremely low gestational age. J Pediatr Gastroenterol Nutr. 2013;56(5):532–536.
   PubMed Web of Science ®Google Scholar
• Benahmed NA, Manene D, Barbot L, et al. Fecal pancreatic elastase in infants under 2 years of age. Ann Biol Clin. 2008;66(5):549–552.
   PubMed Web of Science ®Google Scholar
• Wieczorek-Filipiak M, Drzymała-Czyż S, Szczepanik M, et al. Fecal elastase-1 in healthy children up to 2 years of age: a cross-sectional study. Dev Period Med. 2018;22(2):123–127.
   PubMedGoogle Scholar
• Tardelli AC, Camargos PA, Penna FJ, et al. Comparison of diagnostic methods for pancreatic insufficiency in infants with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2013; 56(2):178–181.
   PubMed Web of Science ®Google Scholar
• Münch A, Bührer C, Longardt AC. Digestive enzyme replacement relieves growth failure in preterm infants with poor exocrine pancreatic function: a retrospective case series. Eur J Pediatr. 2021;180(9):2951–2958.
   PubMed Web of Science ®Google Scholar
• Schneider A, Funk B, Caspary W, et al. Monoclonal versus polyclonal ELISA for assessment of fecal elastase concentration: pitfalls of a new assay. Clin Chem. 2005; 51(6):1052–1054.
   PubMed Web of Science ®Google Scholar
• Johnson LM, Spannagl M, Wojtalewicz N, et al. Comparison of fecal calprotectin and pancreatic elastase assays based on proficiency testing results. Clin Biochem. 2022;107:19–23.
   PubMed Web of Science ®Google Scholar
• Lankisch PG, Schmidt I, König H, et al. Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut. 1998;42(4):551–554.
   PubMed Web of Science ®Google Scholar
• Forsmark CE. Diagnosis and management of exocrine pancreatic insufficiency. Curr Treat Options Gastroenterol. 2018; 16(3):306–315.
   PubMedGoogle Scholar
• Hill PG. Faecal fat: time to give it up. Ann Clin Biochem. 2001; 38(Pt 3):164–167.
   PubMedGoogle Scholar
• Nordgaard I, Hansen BS, Mortensen PB. Colon as a digestive organ in patients with short bowel. Lancet. 1994;343(8894):373–376.
   PubMed Web of Science ®Google Scholar
• Wieczorek-Filipiak M, Drzymała-Czyż S, Szczepanik M, et al. Fecal fat concentration and excretion in the first 2 years of life: a cross-sectional study. J Pediatr Gastroenterol Nutr. 2019;68(2):285–289.
   PubMed Web of Science ®Google Scholar
• Caras S, Boyd D, Zipfel L, et al. Evaluation of stool collections to measure efficacy of PERT in subjects with exocrine pancreatic insufficiency. J Pediatr Gastroenterol Nutr. 2011;53(6):634–640.
   PubMed Web of Science ®Google Scholar
• Drummey GD, Benson JA, Jr., Jones CM. Microscopical examination of the stool for steatorrhea. N Engl J Med. 1961; 264:85–87.
   PubMed Web of Science ®Google Scholar
• 9.5.7 Qualitative fecal fat. 4th ed. Leber A, editor. Clinical microbiology procedures handbook Washington, DC: ASM Press; 2016. .
   Google Scholar
• Fine KD, Ogunji F. A new method of quantitative fecal fat microscopy and its correlation with chemically measured fecal fat output. Am J Clin Pathol. 2000;13(4):528–534.
   Google Scholar
• Van De Kamer JH, Pikaar NA, Bolssens-Frankena A, et al. Quantitative determination of the different higher saturated fatty acids in fat from blood, chyle and faeces, by means of partition chromatography on rubber. Biochem J. 1955; 61(2):180–186.
   PubMed Web of Science ®Google Scholar
• Korpi-Steiner NL, Ward JN, Kumar V, et al. Comparative analysis of fecal fat quantitation via nuclear magnetic resonance spectroscopy (1H NMR) and gravimetry. Clin Chim Acta. 2009; 400(1–2):33–36.
   PubMed Web of Science ®Google Scholar
• Appendix: reference intervals. In: Burtis CA, ER, editor. Tietz textbook of clinical chemistry. 2nd ed. Philadelphia, PA: w. B. Saunders and Company; 1991. p. 2187.
   Google Scholar
• Norcia LN, Lundberg WO. Fat excretion: the influence of dietary fat on fecal fat excretion. J Nutr. 1954;54(4):491–508.
   PubMed Web of Science ®Google Scholar
• Thompson GN, Robb TA, Davidson GP. Taurine supplementation, fat absorption, and growth in cystic fibrosis. J Pediatr. 1987;111(4):501–506.
   PubMed Web of Science ®Google Scholar
• Roy SK, Haider R, Akbar MS, et al. Persistent diarrhoea: clinical efficacy and nutrient absorption with a rice based diet. Arch Dis Child. 1990;65(3):294–297.
   PubMed Web of Science ®Google Scholar
• Borowitz D, Aronoff N, Cummings LC, et al. Coefficient of fat absorption to measure the efficacy of pancreatic enzyme replacement therapy in people with cystic fibrosis: gold standard or coal standard? Pancreas. 2022;51(4):310–318.
   PubMed Web of Science ®Google Scholar
• Williams J, MacDonald A, Weller PH, et al. Two enteric coated microspheres in cystic fibrosis. Arch Dis Child. 1990;65(6):594–597.
   PubMed Web of Science ®Google Scholar
• Patchell CJ, Desai M, Weller PH, et al. Creon 10,000 minimicrospheres vs. J Cyst Fibros. 2002; 1(4):287–291.
   PubMedGoogle Scholar
• Johnson L. Screening for gastrointestinal and pancreatic diseases. Adv Clin Chem. 2022;108:129–153.
   PubMedGoogle Scholar
• Paracchini V, Seia M, Raimondi S, et al. Cystic fibrosis newborn screening: distribution of blood immunoreactive trypsinogen concentrations in hypertrypsinemic neonates. JIMD Rep. 2012;4:17–23.
   PubMedGoogle Scholar
• Crockett S, Falck-Ytter Y, Wani S, et al. Acute pancreatitis guideline. Gastroenterology. 2018; 154(4):1102.
   PubMed Web of Science ®Google Scholar
• Bollbach R, Becker M, Rotthauwe HW. Serum immunoreactive trypsin and pancreatic lipase in cystic fibrosis. Eur J Pediatr. 1985;144(2):167–170.
   PubMed Web of Science ®Google Scholar
• Gillard BK, Cox KL, Pollack PA, et al. Cystic fibrosis serum pancreatic amylase. Am J Dis Child. 1984;138(6):577–580.
   PubMedGoogle Scholar
• Dror Y, Donadieu J, Koglmeier J, et al. Draft consensus guidelines for diagnosis and treatment of Shwachman-diamond syndrome. Ann N Y Acad Sci. 2011;1242(1):40–55.
   PubMedGoogle Scholar
• Ventrucci M, Pezzilli R, Gullo L, et al. Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease. Dig Dis Sci. 1989;34(1):39–45.
   PubMed Web of Science ®Google Scholar
• Jacobson DG, Curington C, Connery K, et al. Trypsin-like immunoreactivity as a test for pancreatic insufficiency. N Engl J Med. 1984;310(20):1307–1309.
   PubMed Web of Science ®Google Scholar
• Moore DJ, Forstner GG, Largman C, et al. Serum immunoreactive cationic trypsinogen: a useful indicator of severe exocrine dysfunction in the paediatric patient without cystic fibrosis. Gut. 1986;27(11):1362–1368.
   PubMed Web of Science ®Google Scholar
• Capurso G, Traini M, Piciucchi M, et al. Exocrine pancreatic insufficiency: prevalence, diagnosis, and management. Clin Exp Gastroenterol. 2019;12:129–139.
   PubMed Web of Science ®Google Scholar
• Cleghorn G, Benjamin L, Corey M, et al. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis. Pediatrics. 1986;77(3):301–306.
   PubMed Web of Science ®Google Scholar
• Schumann G, Aoki R, Ferrero C, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 °C. Part 8. Reference procedure for the measurement of catalytic concentration of alpha-amylase [alpha-Amylase: 1,4-alpha-D-glucan 4-glucanohydrolase (AMY), EC 3.2.1.1]. 2006. 01/01.
   Google Scholar
• Mifflin TE, Hamilton M, Hubbard E, et al. Pancreatic amylase measured in serum by use of a monoclonal antibody immunochemically immobilized to a solid phase. Clin Chem. 1989; 35(1):110–114.
   PubMed Web of Science ®Google Scholar
• Panteghini M, Bonora R, Pagani F. Measurement of pancreatic lipase activity in serum by a kinetic colorimetric assay using a new chromogenic substrate. Ann Clin Biochem: Int J Lab Med. 2001;38(4):365–370.
   PubMedGoogle Scholar
• Grosse S, Boyle C, Botkin J, et al. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. Morb Monthly Wkly Rep. 2004;53:1–37.
   PubMedGoogle Scholar
• Hendrix MM, Foster SL, Cordovado SK. Newborn screening quality assurance program for CFTR mutation detection and gene sequencing to identify cystic fibrosis. J Inborn Errors Metab Screen. 2016;4(0):232640981666135.
   Google Scholar
• Southern KW, Munck A, Pollitt R, et al. A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros. 2007;6(1):57–65.
   PubMed Web of Science ®Google Scholar
• Li L, Zhou Y, Bell CJ, et al. Development and characterization of dried blood spot materials for the measurement of immunoreactive trypsinogen. J Med Screen. 2006;13(2):79–84.
   PubMed Web of Science ®Google Scholar
• Dutta SK, Bustin MP, Russell RM, et al. Deficiency of fat-soluble vitamins in treated patients with pancreatic insufficiency. Ann Intern Med. 1982;97(4):549–552.
   PubMed Web of Science ®Google Scholar
• Lindkvist B, MP, Domínguez-Munoz JE. Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: prevalence and diagnostic use. Pancreatology. 2015;15:589–597.
   PubMed Web of Science ®Google Scholar
• Min M, Patel B, Han S, et al. Exocrine pancreatic insufficiency and malnutrition in chronic pancreatitis. Pancreas. 2018;47(8):1015–1018.
   PubMed Web of Science ®Google Scholar
• Sikkens ECM, Cahen DL, Koch A, et al. The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis. Pancreatology. 2013;13(3):238–242.
   PubMed Web of Science ®Google Scholar
• Abu-El-Haija M, Uc A, Werlin SL, et al. Nutritional considerations in pediatric pancreatitis: a position paper from the NASPGHAN pancreas committee and ESPGHAN cystic fibrosis/pancreas working group. J Pediatr Gastroenterol Nutr. 2018;67(1):131–143.
   PubMed Web of Science ®Google Scholar
• Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2002;35(3):246–259.
   PubMedGoogle Scholar
• Karpińska J, Mikołuć B, Motkowski R, et al. HPLC method for simultaneous determination of retinol, alpha-tocopherol and coenzyme Q10 in human plasma. J Pharm Biomed Anal. 2006; 42(2):232–236.
   PubMed Web of Science ®Google Scholar
• Thibeault D, Su H, MacNamara E, et al. Isocratic rapid liquid chromatographic method for simultaneous determination of carotenoids, retinol, and tocopherols in human serum. J Chromatogr B Analyt Technol Biomed Life Sci. 2009; 877(11–12):1077–1083.
   PubMed Web of Science ®Google Scholar
• Thomas JB, Duewer DL, Burdette CQ, et al. Preparation and value assignment of standard reference material 968e fat-soluble vitamins, caretenoids, and cholesterol in human serum. Anal Bioanal Chem. 2012;402(2):749–762.
   PubMed Web of Science ®Google Scholar
• Blomhoff R, Blomhoff HK. Overview of retinoid metabolism and function. J Neurobiol. 2006;66(7):606–630.
   PubMedGoogle Scholar
• Semeraro A, Altieri I, Patriarca M, et al. Evaluation of uncertainty of measurement from method validation data: an application to the simultaneous determination of retinol and α-tocopherol in human serum by HPLC. J Chromatogr B. 2009;877(11):1209–1215.
   PubMed Web of Science ®Google Scholar
• Yuan C, Burgyan M, Bunch DR, et al. Fast, simple, and sensitive high-performance liquid chromatography method for measuring vitamins a and E in human blood plasma. J Sep Sci. 2014;37(17):2293–2299.
   PubMed Web of Science ®Google Scholar
• DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80(6 Suppl):1689S–1696S.
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930.
   PubMed Web of Science ®Google Scholar
• Jukic AMZ, Hoofnagle AN, Lutsey PL. Measurement of vitamin D for epidemiologic and clinical research: Shining light on a complex decision. Am J Epidemiol. 2018;187(4):879–890.
   PubMed Web of Science ®Google Scholar
• Sempos CT, Vesper HW, Phinney KW, et al. Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest Suppl. 2012;243:32–40.
   PubMedGoogle Scholar
• Shearer MJ, Newman P. Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis. J Lipid Res. 2014;55(3):345–362.
   PubMed Web of Science ®Google Scholar
• Mosler K, Von Kries R, Vermeer C, et al. Assessment of vitamin K deficiency in CF—how much sophistication is useful? J Cyst Fibros. 2003;2(2):91–96.
   PubMedGoogle Scholar
• Fusaro M, Gallieni M, Rizzo M, et al. Vitamin K plasma levels determination in human health. Clin Chem Lab Med. 2017;55(6):789–799.
   PubMed Web of Science ®Google Scholar
• Calder PC. Functional roles of fatty acids and their effects on human health. JPEN J Parenter Enteral Nutr. 2015;39(1 Suppl):18S–32S.
   PubMedGoogle Scholar
• Gramlich L, Ireton-Jones C, Miles JM, et al. Essential fatty acid requirements and intravenous lipid emulsions. JPEN J Parenter Enteral Nutr. 2019;43(6):697–707.
   PubMed Web of Science ®Google Scholar
• Mogensen K. Essential fatty acid deficiency. Pract. Gastroenterol. 2017;41(6): 37–44.
   Google Scholar
• Harris WS, Thomas RM. Biological variability of blood omega-3 biomarkers. Clin Biochem. 2010; 2010/02/01/43(3):338–340.
   PubMed Web of Science ®Google Scholar
• Yuzyuk T, Lozier B, Schwarz EL, et al. Intra-individual variability of long-chain fatty acids (C12–C24) in plasma and red blood cells. Prostaglandins Leukot Essent Fatty Acids. 2018;135:30–38.
   PubMed Web of Science ®Google Scholar
• Katan MB, Deslypere JP, van Birgelen AP, et al. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res. 1997;38(10):2012–2022.
   PubMed Web of Science ®Google Scholar
• Balogun KA, Zuromski LM, Kim R, et al. Establishing age-stratified red blood cell fatty acid reference ranges using model-based clustering and iterative application of the harris-boyd method. Clin Biochem. 2021; 97:25–33.
   PubMed Web of Science ®Google Scholar
• Lagerstedt SA, Hinrichs DR, Batt SM, et al. Quantitative determination of plasma c8-c26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders. Mol Genet Metab. 2001;73(1):38–45.
   PubMed Web of Science ®Google Scholar
• Lozier BK, Kim RN, Zuromski LM, et al. Effect of fasting status and other pre-analytical variables on quantitation of long-chain fatty acids in red blood cells. Prostaglandins Leukot Essent Fatty Acids. 2020;163:102211.
   PubMed Web of Science ®Google Scholar
• Kish-Trier E, Schwarz EL, Pasquali M, et al. Quantitation of total fatty acids in plasma and serum by GC-NCI-MS. Clin Mass Spectrom. 2016;2:11–17.
   Google Scholar
• Holman RT. The ratio of trienoic: tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement. J Nutr. 1960;70(3):405–410.
   PubMed Web of Science ®Google Scholar
• Innis SM. Essential fatty acids in growth and development. Prog Lipid Res. 1991;30(1):39–103.
   PubMed Web of Science ®Google Scholar
• Fortson MR, Freedman SN, Webster PD. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol. 1995 ;90(12):2134–2139.
   PubMed Web of Science ®Google Scholar
• Tenner S, Baillie J, DeWitt J, , et al. American college of gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400–1415; 1416. 1416.
   PubMed Web of Science ®Google Scholar
• Yang AL, McNabb-Baltar J. Hypertriglyceridemia and acute pancreatitis. Pancreatology. 2020;20(5):795–800.
   PubMed Web of Science ®Google Scholar
• Kimura W, Mossner J. Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats. Int J Pancreatol. 1996;20(3):177–184.
   PubMedGoogle Scholar
• Christian JB, Arondekar B, Buysman EK, et al. Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia. J Clin Lipidol. 2012; 6(5):450–461.
   PubMed Web of Science ®Google Scholar